av/celldex-therapeutics--big.svg

COM:CELLDEX

Celldex

  • Stock

USD

Last Close

26.22

22/11 21:00

Market Cap

2.41B

Beta: -

Volume Today

662.65K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-22K
-
-213.50K
870.45%
-698.50K
227.17%
-1.38M
97.14%
-892K
35.22%
-1.58M
77.24%
-2.09M
32.10%
-1.41M
32.56%
-987K
29.93%
-259.50K
73.71%
-173.50K
33.14%
average payables
1.49M
-
2.42M
62.18%
2.05M
15.21%
1.62M
21.00%
1.73M
6.44%
1.39M
19.42%
1.12M
19.43%
1.11M
0.94%
1.14M
2.43%
2.28M
100.70%
3.42M
49.61%
average receivables
266.50K
-
458K
71.86%
698.50K
52.51%
1.38M
97.14%
1.83M
33.04%
2.52M
37.61%
2.09M
17.16%
1.41M
32.56%
987K
29.93%
259.50K
73.71%
1.49M
473.22%
book value per share
60.13
-
35.51
40.94%
44.84
26.26%
39.21
12.54%
27.58
29.67%
11.88
56.92%
6.48
45.45%
7.06
8.98%
9.78
38.53%
6.96
28.90%
8.86K
127,226.26%
capex per share
-0.79
-
-0.32
59.20%
-0.75
132.84%
-0.41
46.07%
-0.21
48.67%
-0.08
62.68%
-0.05
35.28%
-0.05
3.91%
-0.03
44.36%
-0.04
33.82%
capex to depreciation
-1.43
-
-0.57
60.41%
-1.22
114.33%
-0.67
44.70%
-0.34
49.91%
-0.21
36.48%
-0.15
29.65%
-0.40
162.51%
-0.41
3.06%
-0.63
55.05%
capex to operating cash flow
0.06
-
0.02
69.53%
0.05
159.55%
0.02
50.64%
0.02
26.48%
0.01
39.60%
0.02
45.74%
0.04
143.90%
0.02
46.62%
0.02
14.06%
capex to revenue
-1.03
-
-0.54
47.58%
-0.89
65.41%
-0.41
54.44%
-0.14
65.39%
-0.09
39.25%
-0.20
140.02%
-0.21
2.26%
-0.27
28.35%
-0.78
188.80%
cash per share
56.97
-
33.73
40.79%
44.80
32.82%
28.04
37.42%
16.27
41.97%
9.00
44.65%
4.44
50.71%
6.56
47.80%
9.52
45.18%
6.50
31.70%
8.74K
134,330.96%
days of inventory on hand
days payables outstanding
350.77
-
days sales outstanding
43.42
-
43.46
0.11%
64.61
48.65%
95.96
48.52%
53.85
43.88%
121.00
124.71%
103.69
14.31%
88.67
14.49%
13.50
84.78%
53.74
298.10%
139.36
159.34%
debt to assets
0.01
-
-0.05
577.03%
0.02
-
0.03
39.63%
0.03
2.41%
0.01
50.38%
0.01
53.65%
0.01
67.13%
0.01
52.25%
debt to equity
0.01
-
-0.06
573.73%
0.03
-
0.04
31.33%
0.04
6.61%
0.02
57.25%
0.01
56.39%
0.01
70.49%
0.01
52.09%
dividend yield
earnings yield
-0.04
-
-0.07
71.41%
-0.08
15.49%
-0.36
327.84%
-0.25
28.74%
-4.83
1,793.93%
-1.56
67.74%
-0.12
92.61%
-0.04
63.02%
-0.06
38.03%
-73.60
125,175.76%
enterprise value
1.76B
-
1.61B
8.85%
1.45B
9.47%
316.95M
78.20%
331.36M
4.55%
11.54M
96.52%
24.78M
114.66%
478.94M
1,833.10%
1.62B
238.33%
2.06B
27.40%
-30.35M
101.47%
enterprise value over ebitda
-22.45
-
-13.23
41.07%
-11.11
16.01%
-2.33
79.07%
-3.45
48.39%
-18.18
426.77%
-0.43
97.66%
-12.54
2,844.01%
-23.99
91.29%
-20.27
15.51%
0.21
101.06%
ev to operating cash flow
-26.04
-
-15.82
39.25%
-14.70
7.04%
-2.80
80.93%
-3.32
18.26%
-0.15
95.37%
-0.53
247.94%
-11.85
2,120.69%
-26.60
124.43%
-19.90
25.19%
ev to sales
428.61
-
447.88
4.50%
265.34
40.76%
46.71
82.40%
26.00
44.33%
1.21
95.35%
6.93
473.02%
64.56
831.11%
348.40
439.61%
875.86
151.40%
-4.41
100.50%
free cash flow per share
-13.52
-
-17.36
28.44%
-16.04
7.62%
-17.11
6.67%
-11.87
30.62%
-7.28
38.64%
-3.25
55.38%
-1.42
56.44%
-1.45
2.43%
-2.25
55.27%
free cash flow yield
-0.04
-
-0.06
70.38%
-0.07
7.52%
-0.32
372.47%
-0.28
13.51%
-2.43
771.31%
-1.46
39.97%
-0.08
94.46%
-0.04
53.56%
-0.05
34.61%
graham net net
51.90
-
27.65
46.73%
37.50
35.63%
10.68
71.52%
7.19
32.72%
6.04
15.95%
2.46
59.22%
5.68
130.67%
8.94
57.30%
5.94
33.53%
8.03K
135,112.03%
graham number
144.03
-
125.82
12.64%
140.83
11.93%
129.44
8.09%
82.08
36.59%
62.21
24.20%
22.50
63.83%
17.90
20.44%
19.03
6.29%
20.25
6.40%
24.12K
119,037.24%
income quality
0.83
-
0.86
3.63%
0.78
9.59%
0.88
13.12%
1.07
22.14%
0.50
53.67%
0.91
83.32%
0.68
25.91%
0.86
27.81%
0.92
6.91%
intangibles to total assets
0.09
-
0.13
43.07%
0.09
29.49%
0.46
392.99%
0.50
10.31%
0.32
35.33%
0.42
30.71%
0.14
65.87%
0.07
53.04%
0.09
30.35%
0.06
34.18%
interest coverage
-87.86
-
-7.61
-
-1.04
86.39%
39.61
-
interest debt per share
0.17
-
0.43
149.52%
-2.60
698.11%
2.63
-
14.90
466.68%
0.25
98.31%
0.12
53.41%
0.07
39.58%
0.02
66.22%
52.47
218,769.94%
inventory turnover
invested capital
0.01
-
-0.06
573.73%
0.03
-
0.04
31.33%
0.04
6.61%
0.02
57.25%
0.01
56.39%
0.01
70.49%
0.01
52.09%
market cap
1.93B
-
1.63B
15.53%
1.52B
6.73%
359.41M
76.38%
365.08M
1.58%
31.33M
91.42%
32.35M
3.27%
519.29M
1,505.20%
1.66B
218.99%
2.09B
26.16%
1.92M
99.91%
net current asset value
277.89M
-
168.63M
39.32%
247.46M
46.74%
77.64M
68.62%
65.50M
15.64%
67.33M
2.79%
37.79M
43.87%
171.36M
353.45%
385.66M
125.06%
291.16M
24.50%
395.24M
35.74%
net debt to ebitda
2.16
-
0.21
90.30%
0.52
146.97%
0.31
39.77%
0.35
12.73%
31.16
8,772.35%
0.13
99.58%
1.06
711.33%
0.53
49.42%
0.25
53.35%
0.23
8.47%
net income per share
-15.33
-
-19.81
29.21%
-19.66
0.77%
-18.99
3.41%
-10.86
42.83%
-14.48
33.38%
-3.47
76.02%
-2.02
41.91%
-1.64
18.45%
-2.62
59.21%
-2.92K
111,374.91%
operating cash flow per share
-12.72
-
-17.04
33.90%
-15.28
10.29%
-16.70
9.27%
-11.66
30.18%
-7.21
38.21%
-3.20
55.59%
-1.36
57.39%
-1.42
4.23%
-2.21
55.71%
payables turnover
1.04
-
receivables turnover
8.41
-
8.40
0.10%
5.65
32.73%
3.80
32.67%
6.78
78.19%
3.02
55.50%
3.52
16.70%
4.12
16.94%
27.04
556.88%
6.79
74.88%
2.62
61.44%
research and ddevelopement to revenue
16.40
-
29.11
77.54%
18.28
37.20%
15.14
17.19%
7.55
50.15%
6.97
7.69%
11.94
71.43%
5.73
51.99%
11.46
99.90%
34.90
204.47%
0.04
99.88%
return on tangible assets
-0.26
-
-0.55
111.84%
-0.42
24.23%
-0.62
48.31%
-0.59
3.79%
-1.44
142.64%
-0.71
50.45%
-0.30
58.38%
-0.17
42.60%
-0.38
124.49%
-0.32
15.55%
revenue per share
0.77
-
0.60
22.16%
0.85
40.77%
1.00
18.37%
1.49
48.31%
0.91
38.57%
0.25
73.04%
0.25
1.61%
0.11
56.65%
0.05
53.67%
142.07
282,514.91%
roe
-0.26
-
-0.56
118.77%
-0.44
21.41%
-0.48
10.44%
-0.39
18.72%
-1.22
209.63%
-0.54
56.04%
-0.29
46.70%
-0.17
41.13%
-0.38
123.92%
-0.33
12.45%
roic
-0.25
-
-0.55
118.31%
-0.47
15.46%
-0.47
0.28%
-0.40
14.98%
-1.21
205.13%
-0.54
55.58%
-0.29
46.57%
-0.17
41.91%
-0.38
125.82%
-0.33
13.57%
sales general and administrative to revenue
3.60
-
5.75
59.68%
6.17
7.37%
5.30
14.13%
1.96
62.99%
2.02
2.96%
4.32
113.71%
1.95
54.86%
4.41
126.04%
11.54
161.92%
4.49
61.07%
shareholders equity per share
60.13
-
35.51
40.94%
44.84
26.26%
39.21
12.54%
27.58
29.67%
11.88
56.92%
6.48
45.45%
7.06
8.98%
9.78
38.53%
6.96
28.90%
8.86K
127,226.26%
stock based compensation to revenue
1.11
-
1.91
72.72%
2.33
21.99%
2.26
3.17%
0.97
57.19%
0.85
12.31%
1.27
50.34%
0.53
58.56%
1.92
264.73%
6.62
244.07%
tangible asset value
288.01M
-
179.17M
37.79%
258.92M
44.51%
90.83M
64.92%
77.80M
14.35%
73.44M
5.61%
41.82M
43.05%
175.18M
318.86%
389.21M
122.18%
294.91M
24.23%
401.98M
36.31%
tangible book value per share
54.15
-
28.56
47.26%
38.63
35.28%
-0.02
100.05%
9.08
43,373.55%
7.03
22.53%
2.88
59.01%
5.91
105.01%
9.08
53.62%
6.29
30.72%
8.30K
131,815.06%
working capital
284.84M
-
180.49M
36.63%
264.70M
46.65%
160.35M
39.42%
117.02M
27.02%
86.48M
26.10%
55.05M
36.34%
183.64M
233.55%
394.31M
114.72%
299.08M
24.15%
400.57M
33.93%

All numbers in USD (except ratios and percentages)